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Objective : There have been no clinical studies regarding the epidemiology and treatment outcome for unruptured intracranial aneurysm (UIA) in
South Korea yet. Thus, The Korean Society of Cerebrovascular Surgery (KSCVS) decided to evaluate the clinical and epidemiological
characteristics, and outcome of the treatment of UIA in 2006, using the nationwide multicenter survey in South Korea. 
Methods : A total of 1,696 cases were enrolled retrospectively over one year at 48 hospitals. The following data were obtained from all patients :
age, sex, presence of symptoms, location and size of the aneurysm, treatment modality, presence of risk factors for stroke, and the postoperative
30-day morbidity and mortality.
Results : The demographic data showed female predominance and peak age of seventh and sixth decades. Supraclinoid internal carotid artery
was the most common site of aneurysms with a mean size of 5.6 mm. Eight-hundred-forty-six patients (49.9%) were treated with clipping, 824
(48.6%) with coiling, and 26 with combined method. The choice of the treatment modalities was related to hospital (p = 0.000), age (p = 0.000),
presence of symptom (p = 0.003), and location of aneurysm (p = 0.000). The overall 30-day morbidity and mortality were 7.4% and 0.3%,
respectively. The 30-day mortality was 0.4% for clipping and 0.2% for coiling, and morbidity was 8.4% for clipping and 6.3% for coiling. Age (p =
0.010), presence of symptoms (p = 0.034), size (p = 0.000) of aneurysm, and diabetes mellitus (p = 0.000) were significant prognostic factors,
while treatment modality was not.
Conclusion : This first nation-wide multicenter survey on UIAs demonstrates the epidemiological and clinical characteristics, outcome and the
prognostic factors of the treatment of UIAs in South Korea. The 30-day postoperative outcome for UIAs seems to be reasonable morbidity and
mortality in South Korea.
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INTRODUCTION
The prevalence of unruptured intracranial aneurysms
(UIAs) has been reported to be between 1 and 6% in
general population, depending on the study cited3,7,13).
Most UIAs remain asymptomatic until they rupture and
cause subarachnoid hemorrhage (SAH) with an annual
incidence of 6-8/100,000 person years in the most recent
studies8). The estimated mortality rate in the first 30 days
post-SAH is in the range of 40 to 50%, and almost half of
the survivors will be left with a neurologic deficit2), despite
the advances of modern medical and surgical management.
The natural history of UIA including annual risk of bleed-
ing has been debated and the best management of patients
with asymptomatic intracranial aneurysms is also currently
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uncertain. New data from the second part of the Interna-
tional Study of UIA showed rupture rates in the range of
0.5-3% per annum. Any prophylactic treatment to prevent
future aneurysm rupture should therefore be very safe.
No reliable nationwide clinical data for the treatment of
UIA has been available in South Korea yet. The Korean
Society of Cerebrovascular Surgery (KSCVS) was founded
in 1986, and the role played by the KSCVS in this area has
been increasingly important, because the incidence of UIAs
increased steadily owing to the advances of noninvasive
imaging of the brain and the increase of the aging popula-
tion. The first nationwide multicenter survey on the treat-
ment of UIA was performed in 2007 for the patients treated
over one year in 2006 by KSCVS. 
The purpose of this study was to identify the clinical and
epidemiological characteristics of the treatment of UIA in
Korea, using this survey data.
We further expect that we could understand UIA treat-
ment outcome in Korea systematically and precisely through
this data. This understanding could hopefully make treat-
ment outcome of the UIA better in South Korea.
MATERIALS AND METHODS
All the patients included in this study was newly diag-
nosed as UIA and treated with clipping, coiling or both
during 1 year period from January 1 to December 31, 2006,
at hospitals in South Korea. Nationwide, 48 hospitals
participated in this project. Forty-one hospitals were uni-
versity hospitals. The participating hospitals were evenly
distributed across the central, southeastern and southwestern
part of the Korean peninsula. All data were collected retro-
spectively from participating hospitals in the form of record-
ed UIA registration sheets, which included following vari-
ables; age, sex, presence of symptoms, location and size of
the aneurysm, treatment modality, presence of risk factors
for stroke, such as hypertension, diabetes mellitus, smoking,
and family history of stroke, and the postoperative 30-day
outcome. The numerical continuous variables such as age
and size of the aneurysm were categorized into 7 in age,
and 6 in size of the aneurysm for statistical analysis. The
30-day clinical outcome was also classified into four cate-
gories : good recovery without deficits, mild disability, severe
disability, and death. Statistical analysis was performed
using SPSS version 15.0 for Windows (SPSS Inc. Chicago,
IL, USA). Chi-square test was applied to evaluate the signifi-
cance of difference in categorical variables in the univariate
analysis, and logistic regression in the multivariate analysis.
A value of p < 0.05 was regarded as statistically significant. 
RESULTS
Patient characteristics 
The 1,696 patients were enrolled in this survey. The 1,696
patients included 499 men (29.4%) and 1,197 women
(70.6%) (Fig. 1). Most patients were in their seventh (n =
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Fig. 3. Clinical presentation of patients with unruptured intracranial aneurysm
according to treatment modality. Symptomatic lesions, such as cranial
neuropathy due to mass effect, headache, dizziness, and coincidence to
other ruptured aneurysms are 41.4%, and asymptomatic lesions, such as
detection from the health care exam and incidental findings on MRA or CTA
are 58.6%. 
Fig. 2. Age distribution of patients with unruptured intracranial aneurysm
according to treatment modality. Regardless of treatment modality, most
patients are in their seventh and sixth decades of life.
Fig. 1. Gender of patients with unruptured intracranial aneurysm according
to treatment modality. Female patients are predominantly included in this
survey in each treatment modality. 
560, 33.0%) and sixth (n = 521,
30.7%) decades of life, followed by
the fifth, eighth, fourth decades of life
(Fig. 2). Symptomatic lesions, such as
cranial neuropathy due to mass effect,
headache, dizziness, and coincidence
with other ruptured aneurysms were
702 (41.4%) and asymptomatic
lesions, such as detection from the
health care survey and incidental
findings on MRA or CTA were 994
(58.6%) (Fig. 3). The hospitals treat-
ing more than100 patients per year
were 5, and the mean number of pati-
ents treated per hospital was 35.3 with
a range from 2 to 203 (Table 1). Many
patients had stroke risk factors; history
of hypertension in 850 (50.1%), dia-
betes mellitus in 185 (10.9%), smok-
ing in 238 (14.0%), and family his-
tory of stroke in 210 patients (12.4%)
(Table 2). 
Characteristics of the 
aneurysms and treatment 
modalities
The location of the aneurysms were
internal carotid artery (ICA) in 647
(38.1%), middle cerebral artery (MCA)
in 445 (26.2%), anterior cerebral
artery (ACA) in 272 (16.0%), and
vertebro-basilar artery (VA-BA) in
153 patients (9.0%) (Fig. 4). Multiple
aneurysms were 166 (10.3%). The
mean size of the aneurysms was 5.6
mm. One-thousand-twenty-two
aneurysms (60.3%) were less than 5
mm in size, 512 were from 6 to 10
mm, and 108 were from 11 to 15 mm
(Fig. 5). The number of intracranial
aneurysms treated during the same
period was 5,229 and the ruptured to
unruptured ratio was 68 : 32. The
treatment modality was clipping for
846 patients (49.9%), coiling for 824
(48.6%) and combined for 26. The
proportion of coiling to clipping was
0.97. For five hospitals treating more
than 100 cases, the average propor-
tion of coiling to clipping was 1.18,
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1 C 66 135 2 203
2 C 38 119 4 161
3 C 101 46 0 147
4 C 72 49 0 121
5 C 57 46 1 104
6 SE 10 66 2 78
7 C 42 28 0 70
8 SE 28 32 0 60
9 SE 45 11 0 56
10 C 19 37 0 56
11 C 10 42 1 53
12 SE 26 21 2 49
13 SE 36 8 0 44
14 SW 31 9 0 40
15 C 26 12 0 38
16 C 18 12 4 34
17 C 20 12 1 33
18 SW 22 4 0 26
19 C 4 19 1 24
20 C 1 20 1 22
21 SE 8 11 2 21
22 C 12 8 1 21
23 SW 18 2 0 20
24 C 3 15 2 20
25 C 11 7 0 18
26 C 14 4 0 18
27 C 6 10 0 16
28 C 3 11 0 14
29 SE 11 1 0 12
30 C 10 0 1 11
31 SE 10 0 0 10
32 C 6 4 0 10
33 C 10 0 0 10
34 SE 9 0 0 9
35 SE 9 0 0 9
36 C 7 0 0 7
37 C 0 7 0 7
38 SW 6 0 0 6
39 C 2 4 0 6
40 C 4 0 1 5
41 C 3 2 0 5
42 C 2 2 0 4
43 C 2 2 0 4
44 C 2 2 0 4
45 C 3 0 0 3
46 C 2 1 0 3
47 C 1 1 0 2
48 C 0 2 0 2
Total 846 824 260 1,696
C : central, SE : southeast, SW : southwest
which was higher than the overall
average. The choice of the treatment
modalities in unruptured aneurysm
was related to patients’ age, symptom,
and location with statistical signifi-
cance. However, sex and size of aneu-
rysm were not significant factors for
choosing the treatment modality. Coil-
ing was also preferred for older (p =
0.000) and asymptomatic (p = 0.003)
patients. Aneurysm location did in-
fluence on the selection of treatment
modality. Aneurysms located on the
internal carotid artery and vertebro-
basilar artery were treated more fre-
quently with coiling, whereas aneury-
sms on the anterior cerebral artery and middle cerebral artery
were treated more frequently with clipping (p = 0.000). 
Postoperative 30-day outcome and prognostic 
factors 
The overall 30-day morbidity and mortality were 7.4%
and 0.3%, respectively. The 30-day mortality was 0.4% for
clipping and 0.2% for coiling, and overall morbidity inclu-
ding mortality was 8.4% for clipping and 6.3% for coiling
(Table 3). While patient’s age (p = 0.016), symptomatic lesion
(p = 0.008), size of the aneurysm (p = 0.000), and smoking
(p = 0.043) were the significant prognostic factors for post-
operative 30-day outcome in univariate analysis, age (p =
0.012), symptomatic lesion (p = 0.008), size (p = 0.001) of
the aneurysm and diabetes mellitus (p = 0.004) were the
significant prognostic factors in multivariate analysis along
with treatment modality (p = 0.021). The different results
were shown in the analysis of the prognostic factors for
postoperative 30-day outcome after separation into clipping
and coiling groups. For clipping group, patients’ age (p =
0.022), the location (p = 0.000) and the size (0.000) of aneu-
rysms were the significant prognostic factors in both univa-
riate and multivariate analyses, and diabetes mellitus (p =
0.005) was added in multivariate analysis. For coiling group,
diabetes mellitus (p = 0.047) was the single significant
factors in multivariate analysis (Table 4).
DISCUSSION
The KCVS is the only society representing the Korean
vascular neurosurgeons and privileged by the Korean Medi-
cal Association. This is the first nationwide survey to assess
the clinical characteristics and the efficacy of the treatment
for UIAs for one year in Korea. Data from forty-eight parti-
cipating hospital in this survey would represent those of the
whole series of unruptured aneurysm in Korea, because we
excluded hospitals that were recently built, or had few new
cases or problematic data collection. The total volume of
the treatment of the cerebral aneurysm in these hospitals
might be estimated almost of all treated UIAs in Korea
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Table 2. Risk factors for stroke according to the treatment modalities
Risk factors
No. of patients (%)
Overall
Clipping Coiling Combined 
Hypertension 427 (50.5) 358 (43.4) 12 (46.2) 797 (47.7)
Diabetes mellitus 86 (10.2) 96 (11.7) 3 (11.5) 185 (10.4)
Smoking 105 (12.4) 126 (15.2) 7 (26.9) 238 (15.0)
Family history of stroke 112 (13.1) 96 (11.7) 2 (7.7) 210 (12.8)
Table 3. Clinical outcome according to the treatment modalities
Clinical outcome
No. of patients (%)
Overall
Clipping Coiling Combined
Good recovery 775 (91.6) 772 (93.7) 24 (92.3) 1,571 (92.6)
Mild disability 57 (6.7) 42 (5.1) 2 (7.7) 101 (6.0)
Severe disability 11 (1.3) 8 (1.0) 0 19 (1.1)
Death 3 (0.4) 2 (0.2) 0 5 (0.3)
Total 846 824 26 1,696
Fig. 4. Location of aneurysms according to treatment modality. Internal
carotid artery before the bifurcation is the most common site of aneurysm.
Multiple aneurysms are 10.6%. ACA : anterior cerebral artery, ICA : internal
carotid artery, MCA : middle cerebral artery, VA-BA : vertebral artery-basilar
artery.
Fig. 5. Size distribution of aneurysms according to treatment modality. The
mean size of the aneurysms is 5.6 mm in maximum diameter.
because this study has been designed and cooperated with
large hospitals participating in the cerebrovascular surgery
and the neurosurgery resident training program in Korea. 
A recent systematic review regarding UIAs from many
countries reported a prevalence of 0.4% and 3.6% in retro-
spective and prospective autopsy studies, respectively, and
3.7% and 6.0% in retrospective and prospective angiogra-
phic studies, respectively12). Number of new patients with
treated UIA during recent five years has continuously incre-
ased during the 5-year period between 2002 and 2006
(data from the KCVS registry). The proportion of UIA to
ruptured intracranial aneurysm has also increased to 32%
in 2006, from 20% in 2002 (data from the KCVS registry).
The increasing tendency for the UIA to be treated over
recent years reflects the advances of the neuroimaging
modality, such as CT angiography and MR angiography
with sensitivity of 76 to 98% and specificity of 85 to 100%.14)
In Korea, the KCVS has made propaganda for the early
detection of the UIA to a nation since 2003, which may con-
tribute to this increasing tendency.
Like the other nationwide survey on the treatment of
UIAs6), there were female and 6th and 7th decades predo-
minance in our study. In their metaanaysis of ruptured
intracranial aneurysm from 21 countries, De Rooij et al.4)
reported that the incidence in women was 1.24 times
higher than in men and that incidence ratios increased
from 0.10 for the younger than 25 years to 1.61 for the older
than 85 years. In this study the number of treated UIAs
also increased with age except for the 8th decade, probably
because many neurosurgeons had a tendency to left untre-
ated the UIAs in this extreme old age.
The average size of the treated UIA at this survey was 5.6
mm and 60.3% of them were less than 5 mm. The treat-
ment policy of UIAs is related to the natural history, or
rupture rate Data from the second part of the International
Study of Unruptured Intracranial Aneurysms (ISUIA) in
2003 showed rupture rates in the range
of 0.5-3.0% per year, and stratified
the risk according to the lesions’ loca-
tion and size16). They also showed 5-
year cumulative rupture rates for pati-
ents with UIA located in internal
carotid artery, anterior communicating
artery, anterior cerebral artery or mid-
dle cerebral artery which were the
major location in our survey were 0%
for aneurysms less than 7 mm in size16).
According to this randomized cont-
rolled study, most of the aneurysm we
have treated did not need to be treat-
ed. However, possible drawbacks of the ISUIA have been
well known. They had the potential bias in the patient
enrollment and did not explain why the great majority of
ruptured aneurysms seen were less than 7 mm2).
Our survey showed that the determining factors for choos-
ing the treatment modalities were different hospitals,
patients’ age, presence of symptoms and the location of the
aneurysm. Because the treatment of UIAs is so prophylactic
that the treatment modalities should have a very low com-
plication rate, the tendency to coiling is acceptable for treat-
ing older patients, and the UIAs in the posterior circulation.
However, there have been no definite reports on lower
complication rate of coiling for symptomatic aneurysms.
Barker et al.1), comparing the outcome of UIAs for 3,498
clipping and 421 coiling in a retrospective cohort study
using Nationwide Inpatient Sample data from 1996 to
2000, showed that when only death and discharge to long-
term care were taken as poor outcomes, there was no signi-
ficant difference between clipping and coiling, but that on
the basis of a four-level discharge status outcome scale, coiled
patients had a significantly better outcome. In 2003, Ogilvy
and Carter10) at Massachusetts General Hospital retrospec-
tively reviewed their series of 604 UIAs to identify risk
factors. The authors found patient age, aneurysm size, and
location within the posterior circulation to be indepen-
dently associated with poor outcome or death. In our survey,
older age, symptomatic lesion, larger size of the aneurysm,
and diabetes mellitus were related to poor outcome, but the
treatment modality of clipping versus coiling was not a pro-
gnostic factor. Moreover, for the coiling treated group,
patient factors such as age, sex, and the aneurysmal factors,
such as location, size, and symptomatic lesion were not in-
cluded to the prognostic factors. Regardless of treatment
modalities, the common prognostic factors for 30-day out-
come were only different hospitals and diabetes mellitus in
this survey. It is remarkable for diabetes mellitus to be the
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Table 4. Prognostic factors for 30-day surgical outcome





only only only only
Sex 0.277 0.734 0.294 0.171 0.308 0.102
Age 0.016* 0.022* 0.508 0.012* 0.007* 0.504
Presence of symptoms 0.008* 0.052 0.147 0.008* 0.099 0.139
Location of aneurysm 0.172 0.000* 0.187 0.104 0.000* 0.460
Size of aneurysm 0.000* 0.000* 0.210 0.001* 0.000* 0.364
Treatment modality 0.212 - - 0.021* - -
Hypertension 0.557 0.871 0.074 0.277 0.556 0.060
Diabetes mellitus 0.133 0.206 0.410 0.004* 0.005* 0.047*
Smoking 0.043* 0.143 0.128 0.099 0.277 0.234
Family history of stroke 0.680 0.356 0.629 0.475 0.258 0.259
*statistically significant
only prognostic factor for treated UIAs among the other
stroke risk factors, such as hypertension, smoking, and
family history of stroke. The Feigin et al.5) showed a relative
risk of SAH for diabetics compared to non-diabetics of 0.3
(95% CI 0.0 to 2.2) reviewing the relationship between
diabetes and SAH. In this survey, diabetes mellitus was
shown to be also a strong prognostic factor for treated UIAs
as well as for SAH, regardless of the treatment modalities.
The assessment of 1,591 patients in the follow-up ISUIA
study in 2003 showed that 1.8 and 12.0% mortality and
morbidity at 30 days and 2.7 and 10.1% mortality and
morbidity at 1 year15). In 2005, Moroi et al.9) presented
0.3% mortality and 2.2% morbidity overall after treating
549 UIAs. Another single center study by Ogilvy and
Carter10) reported that the overall rates of morbidity and
mortality for the treated UIAs were 15.9 and 0.8%. A
metaanalysis of 2,460 UIAs in 61 publications between
January 1996 and June 1996 reported mortality at 2.1%
and morbidity rate of 10.9% for clipping11). A more recent
study of 3,498 UIAs treated with clipping over five years
reported mortality at 2.1% and death or discharge other
than home at 18.3%1). In our survey, 30-day mortality and
morbidity were 0.3% and 7.4% for overall. These figures
are closer to the better ones in the literature. Taken the
smaller average diameter of the treated UIAs, the non-
randomized retrospective nature of the study, and the short
term of 30 days outcome into account, the outcome in our
survey is comparable to those in the other studies. 
This study has some limitations. Retrospective studies,
without the benefit of randomization, are subject to several
biases, including selection bias. Only 30-day clinical out-
come after each respective treatment was analyzed, and
longer term data including durability of each treatment
modality, were not available. Prospective, randomized trials
comparing the two treatment modalities are mandatory to
evaluate clinical factors related to UIAs outcome that cannot
be addressed in short-term database analyses.
CONCLUSION
This first nation-wide multicenter survey on UIAs demon-
strates the epidemiological and clinical characteristics, out-
come and the prognostic factors of the treatment of UIAs
in South Korea. The 30-day postoperative outcome for
UIAs seems to be reasonable morbidity and mortality in
South Korea.
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